Back to Guides
Weight Loss6 min read

GLP-1 Pills vs. Injections: How the New Weight-Loss Pills Compare

By Peak Medical Wellness · Published

For years, the GLP-1 medications used for weight management came only as weekly injections. That changed in the last year. There are now two once-daily pills approved by the FDA for chronic weight management in adults: oral semaglutide, the active ingredient in the Wegovy® pill, approved in December 2025, and orforglipron, the active ingredient in Foundayo®, approved in April 2026. Peak Medical Wellness doesn't prescribe either brand-name pill. This guide is here so you can understand the options and the trade-offs before you talk with a provider, wherever you get your care. If you're in Northern Colorado, our medical weight loss program in Fort Collins starts with an in-person visit and labs.

What changed

  • Oral semaglutide is the same molecule as the weekly semaglutide injection, made into a daily tablet. A lower-dose semaglutide pill has existed since 2019 for type 2 diabetes (Rybelsus®). The weight-management version is a different, higher-strength product.
  • Orforglipron is a new kind of GLP-1 medicine: a small molecule rather than a peptide, which is part of why it can be taken as a pill without strict fasting rules.

Both are prescription medications for adults with obesity, or with overweight and at least one weight-related health condition. Both are meant to be used alongside changes in eating and activity, as the injections are.

How each is taken

FactorOral semaglutide (daily pill)Orforglipron (daily pill)Weekly GLP-1 injection
How oftenOnce a dayOnce a dayOnce a week
Food and timingFirst thing in the morning on an empty stomach with up to 4 ounces of plain water, then at least 30 minutes before eating, drinking or taking other oral medicinesAny time of day, with or without foodAny day of the week, with or without food
FormTabletTabletPen injection under the skin
Dose increasesStepped up over several monthsStepped up over several monthsStepped up over several months

Do the pills work as well as the shots?

In the main clinical trials, people taking either pill lost meaningfully more weight on average than people taking a placebo. Average weight loss with oral semaglutide was in the same general range as the weekly semaglutide injection. With orforglipron it was somewhat lower, and both pills averaged less than the strongest weekly injections studied. These comparisons come from separate trials, not head-to-head studies. Averages hide a wide range: some people respond strongly, some modestly, and some stop because of side effects. No one can tell you in advance how you will respond. Nothing here is a prediction or a promise.

Side effects and interactions

Side effects are similar for pills and injections. The most common are stomach and digestive effects such as nausea, constipation, diarrhea and vomiting, usually most noticeable when starting or increasing a dose. Two pill-specific points are worth raising with your provider:

  • Timing with other morning medicines. Oral semaglutide has to be taken on an empty stomach before other medicines. That matters if you take thyroid medication or other drugs first thing in the morning.
  • Birth control and other medicines. Orforglipron can affect how some other medications are absorbed, including oral birth control around the start of treatment and after dose increases. Vomiting from any GLP-1 can also affect oral birth control. Tell your provider everything you take.

Who might lean toward a pill, and who might not

  • A pill may appeal to people who have avoided GLP-1 treatment because of needles, or who find a weekly injection hard to keep up with.
  • A daily tablet means a daily habit. People who miss doses easily, or whose mornings don't fit oral semaglutide's fasting window, may find a weekly injection simpler.
  • People already doing well on an injection may have no reason to change. That's a conversation for your provider, not a switch to make on your own.
  • Coverage and out-of-pocket cost vary by plan and pharmacy program for both pills and injections. Check your own plan.

A word about “oral” products sold online

Some online sellers market compounded “oral semaglutide,” drops or dissolving tablets. These are not the FDA-approved pills described here, and the FDA has warned companies about how compounded GLP-1 products are marketed. Our guide to the FDA's warning letters on compounded GLP-1s explains what to watch for.

How a provider helps you choose

The right form depends on your health history, the other medicines you take, how a daily or weekly routine fits your life, and what you've tried before. At Peak Medical Wellness, weight-loss care starts with an in-person visit and labs drawn in our office, and a provider who talks through your options plainly. That includes medications we don't prescribe, so you can make an informed choice.

Frequently Asked Questions

Is there a GLP-1 pill for weight loss?

Yes. Two once-daily pills are FDA-approved for chronic weight management in adults: oral semaglutide (approved December 2025) and orforglipron (approved April 2026).

Is the semaglutide pill the same as the shot?

It contains the same active ingredient, semaglutide, but it is a different product, taken daily with strict timing rules. Results and side effects in trials were in the same general range, not identical.

Do I have to fast to take a GLP-1 pill?

Oral semaglutide is taken on an empty stomach with a little water, followed by a wait before eating, drinking or taking other medicines. Orforglipron can be taken any time, with or without food.

Are GLP-1 pills less effective than injections?

On average in clinical trials, both pills produced meaningful weight loss compared with placebo. Oral semaglutide was in the same general range as weekly semaglutide injections; orforglipron was somewhat lower; both were less than the strongest weekly injections. Individual results vary.

Does Peak Medical Wellness prescribe GLP-1 pills?

No. Peak Medical Wellness does not prescribe the brand-name GLP-1 pills. Our providers can talk through how they compare with other options at an in-person visit.

Are compounded oral semaglutide drops the same as the approved pill?

No. Compounded "oral" semaglutide products are not FDA-approved and are not the same as the approved tablet.

Talk Through Your Options in Fort Collins

Weight-loss care at Peak Medical Wellness starts with an in-person visit and labs. Book a consultation or call, and a provider will walk you through your options plainly.

Learn more about medical weight loss in Fort Collins.

Sources

  1. Healio: FDA approves oral semaglutide, the first oral GLP-1 for obesity (December 2025).
  2. Healio: FDA approves orforglipron, an oral GLP-1 for adults with obesity (April 2026).
  3. Wharton S, et al. Oral semaglutide in adults with overweight or obesity (OASIS 4). N Engl J Med. 2025.
  4. Wharton S, Aronne LJ, et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment (ATTAIN-1). N Engl J Med. 2025.
  5. Yale Medicine: GLP-1 weight-loss pills: what you need to know (April 2026).
  6. FDA: prescribing information for oral semaglutide tablets for weight management (2026).
  7. Eli Lilly: prescribing information for orforglipron tablets.
  8. Lilly Medical: orforglipron and oral contraceptives.

Results disclaimer: Individual results vary. Outcomes depend on each patient's unique health profile, treatment adherence, and other individual factors. Peak Medical Wellness does not guarantee specific results.